Home › Calculator › CSPHF Dividend Calculator 2026
CSPHF Dividend DRIP Calculator 2026
285.71% YieldHealthcareCStone Pharmaceuticals · OTC
Price: $0.70 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CSPHF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your CSPHF snowball 📈
$10,000 in CSPHF → $17760209928775020.00M in 10 years · $1,479,511,801,554,288,200,000.00/month
About CStone Pharmaceuticals (CSPHF) — Dividend Analysis 2026
CStone Pharmaceuticals is a biopharmaceutical firm dedicated to discovering, developing, and marketing innovative immuno-oncology and precision medicine therapies. Their primary objective is to fulfill critical medical requirements for cancer patients, both within China and across global markets. The company currently provides several key therapeutic agents. These include Sugemalimab, a monoclonal antibody specifically targeting programmed death-ligand 1 (PD-L1); GAVRETO, an RET inhibitor prescribed for advanced or metastatic RET-mutant medullary and RET fusion-positive thyroid cancers; and avapritinib, a KIT/PDGFRA inhibitor used in adults with unresectable or metastatic gastrointestinal stromal tumors that carry a PDGFRA exon 18 mutation. CStone's robust product pipeline features promising candidates such as Nofazinlimab, a PD-1 antibody aimed at treating hepatocellular carcinoma; Ivosidenib, an isocitrate dehydrogenase 1 (IDH1) inhibitor developed for adults experiencing relapsed or refractory acute myeloid leukemia with an IDH1 mutation; and Fisogatinib, an FGFR4 inhibitor also indicated for hepatocellular carcinoma. Further augmenting its development portfolio are various compounds including CS1002, CS2006, CS3002, CS3005, CS2007, CS2008, and CS500, all targeting solid tumors, alongside CS5001, which addresses both solid tumors and hematologic malignancies. Established in 2015, CStone Pharmaceuticals maintains its headquarters in Shanghai, China.
Compare CSPHF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CSPHF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CSPHF position with:
🌍 CSPHF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CSPHF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 285.71% | 282.91% | $28,571 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 242.85% | 240.05% | $24,285 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 228.57% | 225.77% | $22,857 / yr |
| 🇬🇧 UK ISA | 0% | 285.71% | 282.91% | $28,571 / yr |
| 🇬🇧 UK Taxable | 8.75% | 260.71% | 257.91% | $26,071 / yr |
| 🇨🇦 TFSA | 0% | 285.71% | 282.91% | $28,571 / yr |
| 🇨🇦 CA Taxable | 25% | 214.28% | 211.48% | $21,428 / yr |
| 🇦🇺 Super (pension) | 15% | 242.85% | 240.05% | $24,285 / yr |
| 🇦🇺 AU Taxable | 30% | 200.00% | 197.20% | $20,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 210.35% | 207.55% | $21,035 / yr |
| 🇫🇷 FR Taxable | 30% | 200.00% | 197.20% | $20,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CSPHF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CSPHF Dividend Payment Schedule
CSPHF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 CSPHF vs Healthcare Benchmarks
How CSPHF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CSPHF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CSPHF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CSPHF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
CStone Pharmaceuticals (CSPHF) is currently trading at $0.70, 65% below its 52-week high. The current dividend yield is 285.71% based on an annual payout of $2.00 per share.
CSPHF (CStone Pharmaceuticals) — 285.71% Dividend Yield Analysis
CStone Pharmaceuticals (CSPHF) is a healthcare stock currently trading at $0.70 with a dividend yield of 285.71%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (285.71%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.